Skip to main content
Top
Published in: BMC Infectious Diseases 1/2010

Open Access 01-12-2010 | Research article

The epidemiology of hematogenous vertebral osteomyelitis: a cohort study in a tertiary care hospital

Authors: Kavita P Bhavan, Jonas Marschall, Margaret A Olsen, Victoria J Fraser, Neill M Wright, David K Warren

Published in: BMC Infectious Diseases | Issue 1/2010

Login to get access

Abstract

Background

Vertebral osteomyelitis is a common manifestation of osteomyelitis in adults and associated with considerable morbidity. Limited data exist regarding hematogenous vertebral osteomyelitis. Our objective was to describe the epidemiology and management of hematogenous vertebral osteomyelitis.

Methods

We performed a 2-year retrospective cohort study of adult patients with hematogenous vertebral osteomyelitis at a tertiary care hospital.

Results

Seventy patients with hematogenous vertebral osteomyelitis were identified. The mean age was 59.7 years (±15.0) and 38 (54%) were male. Common comorbidities included diabetes (43%) and renal insufficiency (24%). Predisposing factors in the 30 days prior to admission included bacteremia (19%), skin/soft tissue infection (17%), and having an indwelling catheter (30%). Back pain was the most common symptom (87%). Seven (10%) patients presented with paraplegia. Among the 46 (66%) patients with a microbiological diagnosis, the most common organisms were methicillin-susceptible S. aureus [15 (33%) cases], and methicillin-resistant S. aureus [10 (22%)]. Among the 44 (63%) patients who had a diagnostic biopsy, open biopsy was more likely to result in pathogen recovery [14 (93%) of 15 with open biopsy vs. 14 (48%) of 29 with needle biopsy; p = 0.003]. Sixteen (23%) patients required surgical intervention for therapeutic purposes during admission.

Conclusions

This is one of the largest series of hematogenous vertebral osteomyelitis. A microbiological diagnosis was made in only approximately two-thirds of cases. S. aureus was the most common causative organism, of which almost half the isolates were methicillin-resistant.
Literature
1.
go back to reference Waldvogel FA, Medoff G, Swartz MN: Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med. 1970, 282: 198-206. 10.1056/NEJM197001222820406.CrossRefPubMed Waldvogel FA, Medoff G, Swartz MN: Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med. 1970, 282: 198-206. 10.1056/NEJM197001222820406.CrossRefPubMed
2.
go back to reference Khan IA, Vaccaro AR, Zlotolow DA: Management of vertebral diskitis and osteomyelitis. Orthopedics. 1999, 22: 758-65.PubMed Khan IA, Vaccaro AR, Zlotolow DA: Management of vertebral diskitis and osteomyelitis. Orthopedics. 1999, 22: 758-65.PubMed
3.
go back to reference Calhoun JH, Manring MM: Adult osteomyelitis. Infect Dis Clin North Am. 2005, 19: 765-86. 10.1016/j.idc.2005.07.009.CrossRefPubMed Calhoun JH, Manring MM: Adult osteomyelitis. Infect Dis Clin North Am. 2005, 19: 765-86. 10.1016/j.idc.2005.07.009.CrossRefPubMed
4.
go back to reference Carragee EJ: Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am. 1997, 79: 874-80. 10.1302/0301-620X.79B5.8078.CrossRefPubMed Carragee EJ: Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am. 1997, 79: 874-80. 10.1302/0301-620X.79B5.8078.CrossRefPubMed
5.
go back to reference Ozuna RM, Delamarter RB: Pyogenic vertebral osteomyelitis and postsurgical disc space infections. Orthop Clin North Am. 1996, 27: 87-94.PubMed Ozuna RM, Delamarter RB: Pyogenic vertebral osteomyelitis and postsurgical disc space infections. Orthop Clin North Am. 1996, 27: 87-94.PubMed
6.
go back to reference McHenry MC, Easley KA, Locker GA: Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis. 2002, 34: 1342-50. 10.1086/340102.CrossRefPubMed McHenry MC, Easley KA, Locker GA: Vertebral osteomyelitis: long-term outcome for 253 patients from 7 Cleveland-area hospitals. Clin Infect Dis. 2002, 34: 1342-50. 10.1086/340102.CrossRefPubMed
7.
go back to reference Hadjipavlou AG, Mader JT, Necessary JT, Muffoletto AJ: Hematogenous pyogenic spinal infections and their surgical management. Spine (Phila Pa 1976). 2000, 25: 1668-79.CrossRef Hadjipavlou AG, Mader JT, Necessary JT, Muffoletto AJ: Hematogenous pyogenic spinal infections and their surgical management. Spine (Phila Pa 1976). 2000, 25: 1668-79.CrossRef
8.
go back to reference Elixhauser A, Steiner C: Infections with methicillin-resistant Staphylococcus aureus (MRSA) in U.S. hospitals, 1993-2005. Agency for Healthcare Research and Quality Statistical Brief. 2007, 35: 1-10. Elixhauser A, Steiner C: Infections with methicillin-resistant Staphylococcus aureus (MRSA) in U.S. hospitals, 1993-2005. Agency for Healthcare Research and Quality Statistical Brief. 2007, 35: 1-10.
9.
go back to reference Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al: Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005, 352: 1436-44. 10.1056/NEJMoa043252.CrossRefPubMed Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al: Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005, 352: 1436-44. 10.1056/NEJMoa043252.CrossRefPubMed
10.
go back to reference Livorsi DJ, Daver NG, Atmar RL, Shelburne SA, White AC, Musher DM: Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA era. J Infect. 2008, 57: 128-31. 10.1016/j.jinf.2008.04.012.CrossRefPubMed Livorsi DJ, Daver NG, Atmar RL, Shelburne SA, White AC, Musher DM: Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA era. J Infect. 2008, 57: 128-31. 10.1016/j.jinf.2008.04.012.CrossRefPubMed
11.
go back to reference Priest DH, Peacock JE: Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomes. South Med J. 2005, 98: 854-62. 10.1097/01.smj.0000168666.98129.33.CrossRefPubMed Priest DH, Peacock JE: Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: clinical features and therapeutic outcomes. South Med J. 2005, 98: 854-62. 10.1097/01.smj.0000168666.98129.33.CrossRefPubMed
12.
go back to reference Belzunegui J, Intxausti JJ, De Dios JR, Del Val N, Rodriguez Valverde V, Gonzalez C, et al: Haematogenous vertebral osteomyelitis in the elderly. Clin Rheumatol. 2000, 19: 344-7. 10.1007/PL00011175.CrossRefPubMed Belzunegui J, Intxausti JJ, De Dios JR, Del Val N, Rodriguez Valverde V, Gonzalez C, et al: Haematogenous vertebral osteomyelitis in the elderly. Clin Rheumatol. 2000, 19: 344-7. 10.1007/PL00011175.CrossRefPubMed
13.
go back to reference Darouiche RO, Landon GC, Klima M, Musher DM, Markowski J: Osteomyelitis associated with pressure sores. Arch Intern Med. 1994, 154: 753-8. 10.1001/archinte.154.7.753.CrossRefPubMed Darouiche RO, Landon GC, Klima M, Musher DM, Markowski J: Osteomyelitis associated with pressure sores. Arch Intern Med. 1994, 154: 753-8. 10.1001/archinte.154.7.753.CrossRefPubMed
14.
go back to reference Krogsgaard MR, Wagn P, Bengtsson J: Epidemiology of acute vertebral osteomyelitis in Denmark: 137 cases in Denmark 1978-1982, compared to cases reported to the National Patient Register 1991-1993. Acta Orthop Scand. 1998, 69: 513-7. 10.3109/17453679808997789.CrossRefPubMed Krogsgaard MR, Wagn P, Bengtsson J: Epidemiology of acute vertebral osteomyelitis in Denmark: 137 cases in Denmark 1978-1982, compared to cases reported to the National Patient Register 1991-1993. Acta Orthop Scand. 1998, 69: 513-7. 10.3109/17453679808997789.CrossRefPubMed
15.
go back to reference Jaramillo-de la Torre JJ, Bohinski RJ, Kuntz C: Vertebral osteomyelitis. Neurosurg Clin N Am. 2006, 17: 339-51. 10.1016/j.nec.2006.05.003. viiCrossRefPubMed Jaramillo-de la Torre JJ, Bohinski RJ, Kuntz C: Vertebral osteomyelitis. Neurosurg Clin N Am. 2006, 17: 339-51. 10.1016/j.nec.2006.05.003. viiCrossRefPubMed
16.
go back to reference Rankine JJ, Barron DA, Robinson P, Millner PA, Dickson RA: Therapeutic impact of percutaneous spinal biopsy in spinal infection. Postgrad Med J. 2004, 80: 607-9. 10.1136/pgmj.2003.017863.CrossRefPubMedPubMedCentral Rankine JJ, Barron DA, Robinson P, Millner PA, Dickson RA: Therapeutic impact of percutaneous spinal biopsy in spinal infection. Postgrad Med J. 2004, 80: 607-9. 10.1136/pgmj.2003.017863.CrossRefPubMedPubMedCentral
17.
go back to reference Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N: Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980-1990. J Infect. 1997, 34: 113-8. 10.1016/S0163-4453(97)92395-1.CrossRefPubMed Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N: Increasing frequency of vertebral osteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980-1990. J Infect. 1997, 34: 113-8. 10.1016/S0163-4453(97)92395-1.CrossRefPubMed
18.
go back to reference Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y: The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005, 26: 166-74. 10.1086/502522.CrossRefPubMed Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y: The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005, 26: 166-74. 10.1086/502522.CrossRefPubMed
19.
go back to reference Soriano A, Marco F, Martinez JA, Pisos E, Almela M, Dimova VP, et al: Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008, 46: 193-200. 10.1086/524667.CrossRefPubMed Soriano A, Marco F, Martinez JA, Pisos E, Almela M, Dimova VP, et al: Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008, 46: 193-200. 10.1086/524667.CrossRefPubMed
Metadata
Title
The epidemiology of hematogenous vertebral osteomyelitis: a cohort study in a tertiary care hospital
Authors
Kavita P Bhavan
Jonas Marschall
Margaret A Olsen
Victoria J Fraser
Neill M Wright
David K Warren
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2010
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-10-158

Other articles of this Issue 1/2010

BMC Infectious Diseases 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.